Ashlynne Clark, MD
Dermatology · Cedar Rapids, IANPI 1932410867
Payments from drug & device makers
What this record shows
This record is dominated by education: $92 of the $120 with a category attached, or 77.1%. Johnson & Johnson accounts for 64.4% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2019 at $92 and has fallen 83.3% since, to $15 in 2023. That places this record below the midpoint for dermatology clinicians in IA, where the typical reported total is $716.
Across 4 payments — averaging $29.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$77
- AbbVie$27
- Pfizer$15
Across 3 payments — averaging $69.48 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Daiichi Sankyo Inc.$208
Across 7 payments — averaging $15,622 each. An ownership or investment interest held by the physician or an immediate family member.
- Digital Diagnostics Inc.$109K
What the payments were for
- Food & beverage$2723%
- Education$9277%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 1 | $77 |
| AbbVie(2 entities) | 2 | $27 |
| Pfizer | 1 | $15 |
How this compares
$120 in reported general payments places this provider in the 15th percentile of 92 dermatology providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluorouracil | 20 | $1,881 |
| Doxycycline Monohydrate | 45 | $615 |
| Cephalexin | 114 | $367 |
| Mupirocin | 34 | $190 |
| ValacyclovirValacyclovir Hcl | 13 | $135 |
| Amoxicillin | 12 | $21 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Cedar Rapids
- David KnutsonCedar Rapids$60K
- John WollnerCedar Rapids$2K
- Lauren DoughtymcdonaldCedar Rapids$1K
- Stacy KirbyCedar Rapids$863
- Emily BoesCedar Rapids$503
- Mark ClevelandCedar Rapids$500
- Matthew LandherrCedar Rapids$413
- Roger CeilleyWest Des Moines$82K
- Scott GreenFort Dodge$56K
- Timothy AbrahamsonUrbandale$49K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.